+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Hormonal counterregulation and consecutive glimepiride serum concentrations during severe glimepiride-induced hypoglycemia



Hormonal counterregulation and consecutive glimepiride serum concentrations during severe glimepiride-induced hypoglycemia



Diabetes & Metabolism 29(Hors serie 2): 4S256




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 035045565

Download citation: RISBibTeXText


Related references

Hormonal counterregulation and consecutive glimepiride serum concentrations during severe hypoglycaemia associated with glimepiride therapy. European Journal of Clinical Pharmacology 59(10): 747-754, 2003

A case of hypoglycemia caused by the accidental ingestion of glimepiride in an elderly dementia patient diagnosed based on the serum glimepiride concentration. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 50(4): 550-554, 2014

The diagnostic value of determining the hydroxy metabolite of glimepiride (M1) in blood serum in cases of severe hypoglycaemia associated with glimepiride therapy. Diabetes, Obesity and Metabolism 6(5): 391-393, 2004

Effects Of Glimepiride And Glyburide On Glucose Counterregulation And Recovery From Hypoglycemia. Journal of Investigative Medicine 53(1): S297.2-S297, 2005

Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia. Metabolism: Clinical and Experimental 55(1): 78-83, 2005

Higher Risk of Hypoglycemia with Glimepiride Versus Vildagliptin in Patients with Type 2 Diabetes is not Driven by High Doses of Glimepiride: Divergent Patient Susceptibilities?. Diabetes Therapy 5(2): 459-469, 2014

Glimepiride-Induced Hypoglycemia With Ciprofloxacin, Metronidazole, and Acute Kidney Injury. Hospital Pharmacy 45(12): 934-938, 2010

Glycemic and extraglycemic effects of glimepiride plus pioglitazone vs glimepiride plus rosiglitazone therapy in type 2 diabetic patients. Diabetes & Metabolism 29(Hors serie 2): 4S249, 2003

Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. II. Photoaffinity labeling of a 65 kDa protein by [3H]glimepiride. Biochimica et Biophysica Acta 1191(2): 278-290, 1994

Comparative study to evaluate the effect of l-carnitine plus glimepiride versus glimepiride alone on insulin resistance in type 2 diabetic patients. Diabetes & Metabolic Syndrome 13(1): 167-173, 2019

Comparison between glimepiride plus pioglitazone vs glimepiride plus rosiglitazone on glucose metabolism and on lipid, lipoprotein and apolipoprotein fractions in Type 2 diabetic patients. Diabetes 52(Suppl. 1): A458-A459, 2003

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin. Diabetes, Obesity and Metabolism 9(5): 733-745, 2007

Glimepiride monotherapy versus combination of glimepiride and linagliptin therapy in patients with HNF1A-diabetes: a protocol for a randomised, double-blinded, placebo-controlled trial. BMJ Open 8(10): E022517, 2018

Glimepiride, a new once-daily sulfonylurea. A double-blind placebo-controlled study of NIDDM patients. Glimepiride Study Group. Diabetes Care 19(11): 1194-1199, 1996

A dose-response study of glimepiride in patients with NIDDM who have previously received sulfonylurea agents. The Glimepiride Protocol #201 Study Group. Diabetes Care 19(8): 849-856, 1996